Sowell Joseph A III
SVP; Chief Development Officer at HCA
- Sold, on record
- $36.8M
- Dollars the filings state
- Form 4 sales
- 9
- Latest Oct 28, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- HCAHCA Healthcare, Inc.SVP; Chief Development Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale HCAUnusualJan 26, 2018 2018
Sold 58,175 shares at $95.00 ($5.5M)
Sowell Joseph A III, SVP; Chief Development Officer
Sold 91.5% of holdings ($6M position)5,386 shares leftFirst sale on recordFiling
- 2 Form 4 sale HCAPlan not statedJan 30, 2018 +4 days
Sold 22,025 shares at $101.86 ($2.2M)
Sowell Joseph A III, SVP; Chief Development Officer
Sold 24% of holdings ($9.3M position)69,732 shares leftFiling
- 3 Form 4 sale HCAUnusualFeb 1, 2018 +2 days
Sold 30,195 shares at $101.02 ($3.1M)
Sowell Joseph A III, SVP; Chief Development Officer
Sold 84.9% of holdings ($3.6M position)5,386 shares leftFiling
- 4 Form 4 sale HCAUnusualJan 29, 2020 +727 days
Sold 31,063 shares at $145.30 ($4.5M)
Sowell Joseph A III, SVP; Chief Development Officer
Sold 98% of holdings ($4.6M position)646 shares leftFiling
- 5 Form 4 sale HCAUnusualFeb 4, 2020 +6 days
Sold 21,309 shares at $145.00 ($3.1M)
Sowell Joseph A III, SVP; Chief Development Officer
Sold 97.1% of holdings ($3.2M position)646 shares leftFiling
- 6 Form 4 sale HCAUnusualJan 4, 2022 +700 days
Sold 22,198 shares at $259.23 ($5.8M)
Sowell Joseph A III, SVP; Chief Development Officer
Sold 64.2% of holdings ($9M position)12,357 shares leftFiling
- 7 Form 4 sale HCAUnusualMar 11, 2022 +66 days
Sold 11,522 shares at $269.00 ($3.1M)
Sowell Joseph A III, SVP; Chief Development Officer
Sold 40.3% of holdings ($7.7M position)17,051 shares leftFiling
- 8 Form 4 sale HCAUnusualOct 28, 2022 +231 days
Sold 12,946 shares at $223.18 ($2.9M)
Sowell Joseph A III, SVP; Chief Development Officer
Sold 100% of holdings ($2.9M position)0 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 2022 | Nov 1, 2022 | HCA | SVP; Chief Development Officer | Form 4 sale | 12,946 | $2.9M | 100.0% | Unusual | SEC |
| Mar 11, 2022 | Mar 15, 2022 | HCA | SVP; Chief Development Officer | Form 4 sale | 11,522 | $3.1M | 40.3% | Unusual | SEC |
| Jan 4, 2022 | Jan 6, 2022 | HCA | SVP; Chief Development Officer | Form 4 sale | 22,198 | $5.8M | 64.2% | Unusual | SEC |
| Feb 4, 2020 | Feb 6, 2020 | HCA | SVP; Chief Development Officer | Form 4 sale | 21,309 | $3.1M | 97.1% | Unusual | SEC |
| Jan 29, 2020 | Jan 31, 2020 | HCA | SVP; Chief Development Officer | Form 4 sale | 31,063 | $4.5M | 98.0% | Unusual | SEC |
| Feb 1, 2018 | Feb 2, 2018 | HCA | SVP; Chief Development Officer | Form 4 sale | 30,195 | $3.1M | 84.9% | Unusual | SEC |
| Jan 30, 2018 | Feb 1, 2018 | HCA | SVP; Chief Development Officer | Form 4 sale | 22,025 | $2.2M | 24.0% | Plan not stated | SEC |
| Jan 26, 2018 | Jan 30, 2018 | HCA | SVP; Chief Development Officer | Form 4 sale | 58,175 | $5.5M | 91.5% | Unusual | SEC |
| Jul 30, 2014 | Aug 1, 2014 | HCA | SVP; Chief Development Officer | Form 4 sale | 100,000 | $6.6M | 94.4% | Unusual | SEC |